Tags

Type your tag names separated by a space and hit enter

Incidence and Estimated Vaccine Effectiveness Against Symptomatic SARS-CoV-2 Infection Among Persons Tested in US Retail Locations, May 1 to August 7, 2021.
JAMA Netw Open. 2021 Dec 01; 4(12):e2143346.JN

Abstract

This case-control study evaluates the estimated vaccine effectiveness against infection changes over time to help inform public health policy and clinical practices.

Links

PMC Free PDF

Authors+Show Affiliations

Tabak YP
CVS Health, Woonsocket, Rhode Island.
Sun X
CVS Health, Woonsocket, Rhode Island.
Brennan TA
CVS Health, Woonsocket, Rhode Island.
Chaguturu SK
CVS Health, Woonsocket, Rhode Island.

MeSH

AdultCOVID-19COVID-19 VaccinesCase-Control StudiesFemaleHumansIncidenceMaleMiddle AgedPandemicsSARS-CoV-2United StatesVaccine Efficacy

Pub Type(s)

Journal Article

Language

eng

PubMed ID

34935923

Citation

Tabak, Ying P., et al. "Incidence and Estimated Vaccine Effectiveness Against Symptomatic SARS-CoV-2 Infection Among Persons Tested in US Retail Locations, May 1 to August 7, 2021." JAMA Network Open, vol. 4, no. 12, 2021, pp. e2143346.
Tabak YP, Sun X, Brennan TA, et al. Incidence and Estimated Vaccine Effectiveness Against Symptomatic SARS-CoV-2 Infection Among Persons Tested in US Retail Locations, May 1 to August 7, 2021. JAMA Netw Open. 2021;4(12):e2143346.
Tabak, Y. P., Sun, X., Brennan, T. A., & Chaguturu, S. K. (2021). Incidence and Estimated Vaccine Effectiveness Against Symptomatic SARS-CoV-2 Infection Among Persons Tested in US Retail Locations, May 1 to August 7, 2021. JAMA Network Open, 4(12), e2143346. https://doi.org/10.1001/jamanetworkopen.2021.43346
Tabak YP, et al. Incidence and Estimated Vaccine Effectiveness Against Symptomatic SARS-CoV-2 Infection Among Persons Tested in US Retail Locations, May 1 to August 7, 2021. JAMA Netw Open. 2021 Dec 1;4(12):e2143346. PubMed PMID: 34935923.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Incidence and Estimated Vaccine Effectiveness Against Symptomatic SARS-CoV-2 Infection Among Persons Tested in US Retail Locations, May 1 to August 7, 2021. AU - Tabak,Ying P, AU - Sun,Xiaowu, AU - Brennan,Troyen A, AU - Chaguturu,Sreekanth K, Y1 - 2021/12/01/ PY - 2021/12/22/entrez PY - 2021/12/23/pubmed PY - 2022/1/14/medline SP - e2143346 EP - e2143346 JF - JAMA network open JO - JAMA Netw Open VL - 4 IS - 12 N2 - This case-control study evaluates the estimated vaccine effectiveness against infection changes over time to help inform public health policy and clinical practices. SN - 2574-3805 UR - https://www.unboundmedicine.com/medline/citation/34935923/Incidence_and_Estimated_Vaccine_Effectiveness_Against_Symptomatic_SARS_CoV_2_Infection_Among_Persons_Tested_in_US_Retail_Locations_May_1_to_August_7_2021_ DB - PRIME DP - Unbound Medicine ER -